Cargando…
Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review
INTRODUCTION: Pediatric gliomas represent the most common brain tumor in children and its higher grades are associated with higher recurrence and low survival rate. All therapeutic modalities are reported to be insufficient to achieve satisfactory result, with follow-up treatment such as adjuvant ra...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874160/ https://www.ncbi.nlm.nih.gov/pubmed/35191733 http://dx.doi.org/10.1177/10732748211053927 |